SANA Q4 2024 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$51M

Net Income

-$49M

EPS (Diluted)

$-0.21

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$501M

Total Liabilities

$251M

Stockholders' Equity

$251M

Cash & Equivalents

$128M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$51M	-$91M	+43.9%
Net Income	-$49M	-$88M	+44.3%